Cost minimization analysis of treatments for metastatic HER2-positive breast cancer: Fixed-Dose combination of pertuzumab and trastuzumab for subcutaneous injections

Miguel Figallo, María F. Delgado, Mauricio Gonzalez, Adrián Arenas
doi: https://doi.org/10.1101/2023.12.05.23299511

Article usage

Article usage: December 2023 to November 2024

AbstractFullPdf
Dec 2023179728
Jan 2024126318
Feb 202468126
Mar 202444624
Apr 2024581026
May 2024281721
Jun 202429624
Jul 2024322119
Aug 202421820
Sep 2024202725
Oct 2024261535
Nov 2024201410
Back to top
Posted December 06, 2023.
Download PDF
Data/Code
Email
Cost minimization analysis of treatments for metastatic HER2-positive breast cancer: Fixed-Dose combination of pertuzumab and trastuzumab for subcutaneous injections
Miguel Figallo, María F. Delgado, Mauricio Gonzalez, Adrián Arenas
medRxiv 2023.12.05.23299511; doi: https://doi.org/10.1101/2023.12.05.23299511
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area